FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to oncology, and can be used for treating cancer in mammals, particularly lung cancer. That is ensured by administering the folate antimetabolite Pemetrexed in a combination with the antipurine/antipyrimidine endonuclease inhibitor Lucanton in therapeutically effective amounts into a mammal. There are also presented a pharmaceutical composition containing the above ingredients, and a kit comprising two pharmaceutical compositions of the above ingredients.
EFFECT: combination of the specific preparations of the above groups provides a non-manifested increase of the clinical effectiveness of lung cancer in the mammals.
18 cl, 2 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS OF ANTIFOLATE AGENT IN CANCER TREATMENT | 2007 |
|
RU2423114C2 |
| METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S, 4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(THIAZOLYL)-1,8-NAPHTHIRIDINE-3-CARBOXYLIC ACID FOR CANCER TREATMENT | 2006 |
|
RU2592231C2 |
| COMBINATIONS CONTAINING EPOTHILONES AND ANTIMETABOLITES | 2003 |
|
RU2346686C2 |
| COMBINED THERAPY FOR CANCER TREATMENT | 2015 |
|
RU2708374C2 |
| COMBINED CHEMOTHERAPY | 2006 |
|
RU2429838C2 |
| COMBINED CHEMOTHERAPY | 2010 |
|
RU2587013C2 |
| METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THUASOLYL)-1,8-NAPHTHYDIRINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER | 2006 |
|
RU2428983C2 |
| METHOD OF TREATING BREAST CANCER WITH COMPOUND OF 4-IODINE-3-NITROBENZAMINE IN COMBINATION WITH ANTICANCER AGENTS | 2008 |
|
RU2480211C2 |
| MONOCLONAL ANTIBODIES FOR TUMOUR TREATMENT | 2009 |
|
RU2531758C2 |
| CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2675270C2 |
